Previous Article | Next Article 
Journal of Clinical Microbiology, October 1998, p. 2817-2822, Vol. 36, No. 10
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Detection of Resistance to Amphotericin B among
Cryptococcus neoformans Clinical Isolates: Performances of
Three Different Media Assessed by Using E-Test and National
Committee for Clinical Laboratory Standards M27-A
Methodologies
M.
Lozano-Chiu,1,*
V. L.
Paetznick,1
M. A.
Ghannoum,2 and
J.
H.
Rex1
Division of Infectious Diseases, Department
of Internal Medicine, Center for the Study of Emerging and
Reemerging Pathogens, University of Texas Medical School, Houston,
Texas,1 and
Mycology Reference
Laboratory, University Hospitals of Cleveland, Cleveland,
Ohio2
Received 23 March 1998/Returned for modification 15 April
1998/Accepted 7 July 1998
Although reliable detection of resistance in vitro is critical to
the overall performance of any susceptibility testing method, the
recently released National Committee for Clinical Laboratory Standards
M27-A methodology for susceptibility testing of yeasts discriminates
poorly between resistant and susceptible isolates of
Candida spp. We have previously shown that both
substitution of antibiotic medium 3 for RPMI 1640 medium in the
microdilution variant of the M27-A method and use of the E-test agar
diffusion methodology permit detection of amphotericin B-resistant
Candida isolates. To determine the relevance of these
observations to Cryptococcus neoformans, we have evaluated
the performances of both the M27-A and the E-test methodologies with
this yeast using three different media (RPMI 1640 medium, antibiotic
medium 3, and yeast nitrogen base). As with Candida, we
found that only antibiotic medium 3 permitted consistent detection of
resistant isolates when testing was performed in broth by the M27-A
method. When testing was performed by the E-test agar diffusion method, both RPMI 1640 medium and antibiotic medium 3 agar permitted ready detection of the resistant isolates. Reading of the results after 48 h of incubation was required for testing in broth by the M27-A method, while the MIC could be determined after either 48 or 72 h
when the agar diffusion method was used.
*
Corresponding author. Mailing address: 6431 Fannin,
1728 JFB, Houston, TX 77030. Phone: (713) 500-6755. Fax: (713)
500-5495. E-mail: mchiu{at}heart.med.uth.tmc.edu.
Journal of Clinical Microbiology, October 1998, p. 2817-2822, Vol. 36, No. 10
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Illnait-Zaragozi, M.-T., Martinez, G. F., Curfs-Breuker, I., Fernandez, C. M., Boekhout, T., Meis, J. F.
(2008). In Vitro Activity of the New Azole Isavuconazole (BAL4815) Compared with Six Other Antifungal Agents against 162 Cryptococcus neoformans Isolates from Cuba. Antimicrob. Agents Chemother.
52: 1580-1582
[Abstract]
[Full Text]
-
Dias, A. L. T., Matsumoto, F. E., Melhem, M. S. C., da Silva, E. G., Auler, M. E., de Siqueira, A. M., Paula, C. R.
(2006). Comparative analysis of Etest and broth microdilution method (AFST-EUCAST) for trends in antifungal drug susceptibility testing of Brazilian Cryptococcus neoformans isolates.. J Med Microbiol
55: 1693-1699
[Abstract]
[Full Text]
-
Dannaoui, E., Abdul, M., Arpin, M., Michel-Nguyen, A., Piens, M. A., Favel, A., Lortholary, O., Dromer, F., the French Cryptococcosis Study Group,
(2006). Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.. Antimicrob. Agents Chemother.
50: 2464-2470
[Abstract]
[Full Text]
-
Fernandez-Torres, B., Inza, I., Guarro, J.
(2005). Evaluation of Disk Diffusion Method for Determining Eberconazole Susceptibility of Dermatophytes and Influence of Culture Medium. Antimicrob. Agents Chemother.
49: 2116-2118
[Abstract]
[Full Text]
-
Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J., Doern, G. V., Diekema, D. J.
(2005). Global Trends in the Antifungal Susceptibility of Cryptococcus neoformans (1990 to 2004). J. Clin. Microbiol.
43: 2163-2167
[Abstract]
[Full Text]
-
Trilles, L., Fernandez-Torres, B., dos Santos Lazera, M., Wanke, B., Guarro, J.
(2004). In Vitro Antifungal Susceptibility of Cryptococcus gattii. J. Clin. Microbiol.
42: 4815-4817
[Abstract]
[Full Text]
-
Martin-Mazuelos, E., Peman, J., Valverde, A., Chaves, M., Serrano, M. C., Canton, E.
(2003). Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.. J Antimicrob Chemother
52: 365-370
[Abstract]
[Full Text]
-
Maxwell, M. J., Messer, S. A., Hollis, R. J., Diekema, D. J., Pfaller, M. A.
(2003). Evaluation of Etest Method for Determining Voriconazole and Amphotericin B MICs for 162 Clinical Isolates of Cryptococcus neoformans. J. Clin. Microbiol.
41: 97-99
[Abstract]
[Full Text]
-
Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Bouman, B. A., Verweij, P. E.
(2002). Comparison of the Etest and the Sensititre Colorimetric Methods with the NCCLS Proposed Standard for Antifungal Susceptibility Testing of Aspergillus Species. J. Clin. Microbiol.
40: 2876-2885
[Abstract]
[Full Text]
-
Espinel-Ingroff, A., Rezusta, A.
(2002). E-Test Method for Testing Susceptibilities of Aspergillus spp. to the New Triazoles Voriconazole and Posaconazole and to Established Antifungal Agents: Comparison with NCCLS Broth Microdilution Method. J. Clin. Microbiol.
40: 2101-2107
[Abstract]
[Full Text]
-
Pfaller, M. A., Messer, S. A., Mills, K., Bolmstrom, A., Jones, R. N.
(2001). Evaluation of Etest Method for Determining Caspofungin (MK-0991) Susceptibilities of 726 Clinical Isolates of Candida Species. J. Clin. Microbiol.
39: 4387-4389
[Abstract]
[Full Text]
-
Brandt, M. E., Pfaller, M. A., Hajjeh, R. A., Hamill, R. J., Pappas, P. G., Reingold, A. L., Rimland, D., Warnock, D. W.
(2001). Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob. Agents Chemother.
45: 3065-3069
[Abstract]
[Full Text]
-
Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Warnock, D. W.
(2001). Antifungal Susceptibility Testing: Practical Aspects and Current Challenges. Clin. Microbiol. Rev.
14: 643-658
[Abstract]
[Full Text]
-
Cuenca-Estrella, M., Diaz-Guerra, T. M., Mellado, E., Rodriguez-Tudela, J. L.
(2001). Detection of Resistance to Amphotericin B in Candida Isolates by Using Iso-Sensitest Broth. Antimicrob. Agents Chemother.
45: 2070-2074
[Abstract]
[Full Text]
-
Manavathu, E. K., Dimmock, J. R., Vashishtha, S. C., Chandrasekar, P. H.
(2001). Inhibition of H+-ATPase-mediated proton pumping in Cryptococcus neoformans by a novel conjugated styryl ketone. J Antimicrob Chemother
47: 491-494
[Abstract]
[Full Text]
-
Espinel-Ingroff, A.
(2001). Comparison of the E-test with the NCCLS M38-P Method for Antifungal Susceptibility Testing of Common and Emerging Pathogenic Filamentous Fungi. J. Clin. Microbiol.
39: 1360-1367
[Abstract]
[Full Text]
-
Aller, A. I., Martin-Mazuelos, E., Gutierrez, M. J., Bernal, S., Chavez, M., Recio, F. J.
(2000). Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents. J Antimicrob Chemother
46: 997-1000
[Abstract]
[Full Text]
-
Pfaller, M. A., Messer, S. A., Houston, A., Mills, K., Bolmstrom, A., Jones, R. N.
(2000). Evaluation of the Etest Method for Determining Voriconazole Susceptibilities of 312 Clinical Isolates of Candida Species by Using Three Different Agar Media. J. Clin. Microbiol.
38: 3715-3717
[Abstract]
[Full Text]
-
Lopez-Jodra, O., Torres-Rodriguez, J. M., Mendez-Vasquez, R., Ribas-Forcadell, E., Morera-Lopez, Y., Baro-Tomas, T., Alia-Aponte, C.
(2000). In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method. J Antimicrob Chemother
45: 645-649
[Abstract]
[Full Text]
-
Chang Chang, H., Jung Chang, J., Huey Huang, A., Chain Chang, T.
(2000). Evaluation of a Capacitance Method for Direct Antifungal Susceptibility Testing of Yeasts in Positive Blood Cultures. J. Clin. Microbiol.
38: 971-976
[Abstract]
[Full Text]
-
Rodríguez-Tudela, J. L., Martín-Díez, F., Cuenca-Estrella, M., Rodero, L., Carpintero, Y., Gorgojo, B.
(2000). Influence of Shaking on Antifungal Susceptibility Testing of Cryptococcus neoformans: a Comparison of the NCCLS Standard M27A Medium, Buffered Yeast Nitrogen Base, and RPMI-2% Glucose. Antimicrob. Agents Chemother.
44: 400-404
[Abstract]
[Full Text]
-
Lozano-Chiu, M., Arikan, S., Paetznick, V. L., Anaissie, E. J., Rex, J. H.
(1999). Optimizing Voriconazole Susceptibility Testing of Candida: Effects of Incubation Time, Endpoint Rule, Species of Candida, and Level of Fluconazole Susceptibility. J. Clin. Microbiol.
37: 2755-2759
[Abstract]
[Full Text]
-
Lozano-Chiu, M., Nelson, P. W., Paetznick, V. L., Rex, J. H.
(1999). Disk Diffusion Method for Determining Susceptibilities of Candida spp. to MK-0991. J. Clin. Microbiol.
37: 1625-1627
[Abstract]
[Full Text]